Influence of a Food Supplement on the Gut Microbiome in Healthy Obese Women
NCT ID: NCT03223987
Last Updated: 2024-08-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE1/PHASE2
26 participants
INTERVENTIONAL
2017-05-11
2019-11-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Efficacy of a Probiotic Formulation on Energy Balance in Overweight Subjects
NCT01066260
Metabolic Control Before and After Supplementation With Lactobacillus Reuteri DSM 17938 in Type 2 Diabetes Patients
NCT01620125
Effect of Oral Supplementation With Probiotics
NCT03100162
Obesity - Inflammation - Metabolic Disease: Effect of Lactobacillus Casei Shirota
NCT01182844
Metabolomic Effects of Probiotics Administration
NCT04506385
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Participants: healthy obese women between 25 and 35 years. Intervention to be studied: Intake of Strath® Kräuterhefe Original (liquid), Herbal Yeast Food Supplement over 3 weeks, stool analysis.
Sequence and duration of all study periods: 7 weeks per proband.
Week -4 - -2: Pre-Phase Hand out study information First check of inclusion/exclusion criteria
Week -2: Initiation-Phase Signed "Informed Consent" Second check of inclusion/exclusion criteria Complete assessment Part I, II (see 8.2) Start assessment Part IV (see 8.2)
Week 0: Intervention-Phase Implementation of food supplement Complete assessment Part III (see 8.2) Third check of inclusion/exclusion criteria
Week 3: Evaluation-Phase Complete assessment Part II, III and IV Fourth check of inclusion/exclusion criteria Compliance control
5.2 Methods of minimising bias (ICH/E6 6.4.3; AGEK 4.3; SPIRIT #16, 17) ICH: A description of the measures taken to minimize/avoid bias, including: Randomization, Blinding.
Homogenous sample selection. 5.2.1 Randomisation Not applicable
5.2.2 Blinding procedures Not applicable
5.2.3 Other methods of minimising bias The investigators are going to do a semi-quantitative screening to determine a participant's nutritional habits.
Questions about their nutritional habits asked in the screening (via questionnaire);
1. Does the participant have a particular or alternative lifestyle (e.g. vegan, vegetarian, only eating raw fruits and vegetables, etc.)?
\- if yes → excluded
2. Does the participant control your nutrition in any form (food diary, app, counting calories, etc.)?
\- if yes → excluded
3. Does the participant consciously eat food to strengthen your immune system or do you take additional supplements to influence your intestinal bacteria (e.g. pro- and/or prebiotic food like Actimel, Activia, etc.)?
\- if daily or weekly → excluded
4. Does the participant exercise regularly? If yes, how often? - if 3h/week or more → excluded
5. On how many days per week does the participant eat meat or meat products?
\- if less then twice and more than five times peer week → excluded
6. On how many days per week does the participant eat fish?
\- if less or more than twice per week / 5 times per month → excluded
7. On how many days per week does the participant eat salad, vegetables or vegetable juice (not counting potatoes)?
\- if less than 5 days per week → excluded
8. On how many days per week does the participant eat fruits or drink fruit juices approximately?
\- if less than 5 days per week → excluded
9. On how many days per week does the participant drink or eat milk or milk products approximately? - if less than 4 days per week → excluded
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
The study is one armed
Strath® Kräuterhefe Original (liquid)
The food supplement is taken 3 x 1 coffee spoon à 5ml = 15ml per day for three weeks.
Stool analysis at 2nd visit and last visit. Before-after study.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Strath® Kräuterhefe Original (liquid)
The food supplement is taken 3 x 1 coffee spoon à 5ml = 15ml per day for three weeks.
Stool analysis at 2nd visit and last visit. Before-after study.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* German speaking
* Smartphone owner
Exclusion Criteria
* Women who are pregnant or breast feeding,
* Intention to become pregnant during the course of the study,
* Lack of safe contraception, defined as: Female participants of childbearing potential, not using and not willing to continue using a medically reliable method of contraception for the entire study duration, such as oral, injectable, or implantable contraceptives, or intrauterine contraceptive devices, or who are not using any other method considered sufficiently reliable by the investigator in individual cases.
* Please note that female participants who are surgically sterilised / hysterectomised or post-menopausal for longer than 2 years are not considered as being of child bearing potential.
* Other clinically significant concomitant disease states (e.g., renal failure, hepatic dysfunction, cardiovascular disease, etc.),
* Known or suspected non-compliance, drug or alcohol abuse,
* Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia, etc. of the participant,
* Participation in another study with investigational drug within the 30 days preceding and during the present study,
* Enrolment of the investigator, his/her family members, employees and other dependent persons
* any kind of nutritional intervention due to a disease in the past 6 months
* any mean of weight reduction in the past 6 months
* Severe health problems in the last 6 months
* Chronic digestive system problems
* Medication against constipation and diarrhea
* Mental problems
* Major surgery
* Allergies or Atopy
* Drug intolerance
* Antibiotics within 12 months before study
25 Years
35 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Zentrum für Adipositas- und Stoffwechselmedizin Winterthur GmbH
INDUSTRY
Bio-Strath AG
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Peter Joller, PhD
Peter Joller, PhD Clinical Immunology FAMH
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Peter W. Joller, PhD
Role: STUDY_DIRECTOR
Dr.Joller BioMedical Consulting
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Center for Obesity and Metabolism Adimed - Zentrum für Adipositas- und Stoffwechselmedizin Winterthur GmbH Lagerhausstrasse 9
Winterthur, Canton of Zurich, Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
BS2016.1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.